NRC Health

NRC Health

NRCNYSE / NASDAQHealthcareSmall cap

$25.16+$0.17 (+0.7%)

Last close · Data as of Nov 20, 2026

Market cap
$445.1M
P/E
38.4x
EV / EBITDA
17.2x
Revenue
$137.4M
Net margin
8.4%
ROCE
23.0%

+51.5% over the last year

NRC Health price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
+21.6%
3M
+15.3%
6M
+30.6%
1Y
+51.5%
5Y
-40.9%

52-week range

Day change +$0.17 (+0.7%) from $25 to $25 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in NRC, bought on each weekday since 2021.

News & filings

What NRC Health filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

ConcernOperating margin fell for three years, from 26.9% to 16.4%.

Strengths (1)

  • Return on capital employed of 23.0%.
  • Shareholders' equity is small against the company's size, so return on equity and debt to equity are not shown.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States.

Read moreShow less

NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments. It also provides patient experience solutions, a cross-continuum multi-mode digital platform that collects and measures data to improve patient experience, engagement, and loyalty; employee experience solutions, which combines health care with technology comprising engagement, pulse, lifecycle, culture of safety, and magnet RN satisfaction; and consumer experience solution that offers online reputation solutions, community insights, and cross-journey listening through nGage. In addition, the company offers Huey, an AI engine built for Human Understanding that serves as a healthcare experience management companion; and governance solutions provided through national conferences, publications, advisory services, and an online portal for not-for-profit health system boards of directors, executives, and physician leadership. Further, it provides patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. The company was formerly known as National Research Corporation and changed its name to NRC Health April 2026. The company was founded in 1981 and is headquartered in Lincoln, Nebraska.

Sector
Healthcare
Shares outstanding
23.2M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$445.1M
P/E
38.4x
P/B
31.8x
EV / EBITDA
17.2x
EV / Sales
3.8x
P/S
3.2x
52-week high
$27.07
52-week low
$12.03

Profitability

Operating margin
16.4%
Net margin
8.4%
EBITDA margin
22.0%
ROE
82.9%
ROCE
23.0%
ROIC
16.5%
ROA
8.6%
Asset turnover
1.02

Growth

Revenue
$137.4M
Revenue growth, 1Y
-4.0%
Revenue CAGR, 3Y
-3.2%
Net profit growth, 1Y
-53.2%
Free cash flow
$15.7M

Solvency

Current ratio
0.55
Debt / Equity
5.65
Debt / Assets
0.59
CFO / Net profit
2.28
Cash / Market cap
0.9%

Where the revenue went

Of every $100 of FY2025 revenue, $8 was left as net income.

NRC Health income statement flow, FY2025
NRC Health income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$52.4M
RevenueGross profit$85.0M
Gross profitSelling, general and administrative$54.8M
Gross profitOther operating expenses$7.6M
Gross profitOperating income$22.6M
Operating incomePretax income$17.8M
Operating incomeInterest and other expense$4.8M
Pretax incomeTax and other$6.2M
Pretax incomeNet income$11.6M

Revenue and net profit

Revenue fell 4.0% in FY2025; net profit is the dashed line.

NRC Health revenue and net profit by fiscal year
NRC Health revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$151.6M$31.8M
FY2023$148.6M$31.0M
FY2024$143.1M$24.8M
FY2025$137.4M$11.6M

Cash flows

FY2025: $26.4M from operations, $15.7M free after investment (dashed).

NRC Health operating and free cash flow by fiscal year
NRC Health operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$36.3M$26.4M
FY2023$38.1M$22.3M
FY2024$34.6M$19.2M
FY2025$26.4M$15.7M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$137.4M-4.0%1Y
EBITDA
$30.2M-26.8%1Y
Net profit
$11.6M-53.2%1Y
Cash from operations
$26.4M-23.6%1Y
Free cash flow
$15.7M-17.9%1Y
Revenue CAGR, 3Y
-3.2%
Net profit CAGR, 3Y
-28.5%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$137.4M$30.2M$11.6M$15.7M82.9%-4.0%-53.2%

Monthly returns

Month-by-month returns of NRC across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$134.9M
Liabilities$120.9M
Equity$14.0M
Paid-in capital$183.9M
Retained earnings-$17.3M
Treasury stock$152.6M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; NRC highlighted.

P/E against peers

NRC trades at 38.4x earnings against a peer median of -4.8x.

  1. NRC Health (this company)38.4x

Not shown (no positive earnings and no EV / Sales): Rezolute, Inc., Neurogene Inc.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
NRC HealthNRCthis company$445.1M38.4x31.8x82.9%17.2x
Weave Communications, Inc.WEAV$459.1M-16.4x5.6x-34.1%-42.3x
Editas Medicine, Inc.EDIT$458.9M-2.9x16.8x-586.6%-2.2x
Myriad Genetics, Inc.MYGN$443.0M-1.2x1.2x-99.4%-1.5x
Varex Imaging CorporationVREX$440.9M—0.9x-14.9%973.8x
Emergent BioSolutions Inc.EBS$435.5M8.3x0.8x10.1%3.4x
Evolus, Inc.EOLS$434.6M-8.4x-18.8x223.5%-23.8x
Rezolute, Inc.RZLT$434.3M-5.8x2.7x-45.9%-4.3x
Neurogene Inc.NGNE$434.2M-4.8x1.6x-34.1%-3.9x
Peer median—-4.8x1.4x-34.1%-3.1x

Year-to-date ROI

NRC since 1 January, against earlier years.

Historical volatility

NRC's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

NRC Health operating margin by fiscal year
NRC Health operating margin by fiscal year
DateOperating margin
FY202230.7%
FY202326.9%
FY202424.6%
FY202516.4%
LineFY2025
Cost of revenueCost Of Revenue$52.4M
Gross profitGross Profit$85.0M
Operating expensesOperating Expense$62.4M
Selling, general and administrativeSelling General And Administration$54.8M
Depreciation and amortisationDepreciation And Amortization In Income Statement$7.6M
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement$7.6M
Total expensesTotal Expenses$114.8M
Pretax incomePretax Income$17.8M

Learn while you research

Academy chapters picked for NRC Health and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Valuation Multiples ExplainedThis stock trades at a P/E of 38.4, learn when high multiples are justified.6 min read
  3. 03 Leverage RatiosDebt/Equity of 5.65 is elevated, understand what that means for solvency.6 min read
  4. 04 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
  5. 05 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  6. 06 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
Browse the full Equiscale Academy →